Evidence map›Paper›PMID 19193910›Full record

ReviewThe Journal of clinical endocrinology and metabolism2009

Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Shonni J Silverberg, E Michael Lewiecki, Leif Mosekilde, Munro Peacock, Mishaela R Rubin

Abstract readReview
In one paragraph

Review in The Journal of clinical endocrinology and metabolism, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2015
    Trial
  3. Trial
  4. Trial
  5. Evaluating the preoperative diagnostic value ofJournal of applied clinical medical physics · 2026
    Article
  6. Article
  7. Article
  8. [European journal of nuclear medicine and molecular imaging · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. DXA-based bone strain index in normocalcemic primary hyperparathyroidism.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2023
    Article
  13. Normocalcemic primary hyperparathyroidism.Archives of endocrinology and metabolism · 2022
    Review
  14. Review
  15. Article
  16. Article
  17. The EANM practice guidelines for parathyroid imaging.European journal of nuclear medicine and molecular imaging · 2021
    Article
  18. Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shonni J SilverbergColumbia University College of Physicians & Surgeons, 630 West 168th Street, PH 8W-864, New York, New York 10032, USA. sjs5@columbia.edu
E Michael Lewiecki
Leif Mosekilde
Munro Peacock
Mishaela R Rubin

Funding

PRIMARY HYPERPARATHYROIDISM: NON-CLASSICAL MANIFESTATIONSR01DK066329 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SILVERBERG, SHONNI J · 2005 to 2009
$2.6M
Non-Classical Manifestations of Primary HyperparathyroidismK24DK074457 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SILVERBERG, SHONNI J · 2006 to 2016
$1.7M
NIDDK NIH HHS K24 DK074457NIDDK NIH HHS R01 DK066329
6 · The paper itself

Abstract

backgroundAt the Third International Workshop on Asymptomatic Primary Hyperparathyroidism (PHPT) in May 2008, recent data on the disease were reviewed. We present the results of a literature review on issues arising from the clinical presentation and natural history of PHPT.

methodsQuestions were developed by the International Task Force on PHPT. A comprehensive literature search for relevant studies was reviewed, and the questions of the International Task Force were addressed by the Consensus Panel.

conclusions1) Data on the extent and nature of cardiovascular involvement in those with mild disease are too limited to provide a complete picture. 2) Patients with mild PHPT have neuropsychological complaints. Although some symptoms may improve with surgery, available data remain inconsistent on their precise nature and reversibility. 3) Surgery leads to long-term gains in spine, hip, and radius bone mineral density (BMD). Because some patients have early disease progression and others lose BMD after 8-10 yr, regular monitoring (serum calcium and three-site BMD) is essential in those followed without surgery. Patients may present with normocalcemic PHPT (normal serum calcium with elevated PTH concentrations; no secondary cause for hyperparathyroidism). Data on the incidence and natural history of this phenotype are limited. 4) In the absence of kidney stones, data do not support the use of marked hypercalciuria (>10 mmol/d or 400 mg/d) as an indication for surgery for patients. 5) Patients with bone density T-score -2.5 or less at the lumbar spine, hip, or distal one third radius should have surgery.

Indexed as

ConsensusBone DensityCalciumCardiovascular DiseasesCognition DisordersCreatinineHumansHypercalciuriaHyperparathyroidism, PrimaryParathyroidectomyCalciumCreatinine

Identifiers

PMID19193910
PMCPMC5393372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.